rs104886164
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 2P and 12B. PM5BP4_StrongBS1BS2
The NM_033380.3(COL4A5):āc.2215C>Gā(p.Pro739Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000942 in 1,184,160 control chromosomes in the GnomAD database, including 20 homozygotes. There are 341 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P739S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_033380.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL4A5 | ENST00000328300.11 | c.2215C>G | p.Pro739Ala | missense_variant | 28/53 | 1 | NM_033380.3 | ENSP00000331902.7 | ||
COL4A5 | ENST00000483338.1 | c.1039C>G | p.Pro347Ala | missense_variant | 12/20 | 1 | ENSP00000495685.1 | |||
COL4A5 | ENST00000361603.7 | c.2215C>G | p.Pro739Ala | missense_variant | 28/51 | 2 | ENSP00000354505.2 |
Frequencies
GnomAD3 genomes AF: 0.000605 AC: 67AN: 110770Hom.: 1 Cov.: 22 AF XY: 0.000606 AC XY: 20AN XY: 32990
GnomAD3 exomes AF: 0.00116 AC: 175AN: 151506Hom.: 0 AF XY: 0.000907 AC XY: 43AN XY: 47432
GnomAD4 exome AF: 0.000976 AC: 1048AN: 1073345Hom.: 19 Cov.: 28 AF XY: 0.000930 AC XY: 321AN XY: 345329
GnomAD4 genome AF: 0.000605 AC: 67AN: 110815Hom.: 1 Cov.: 22 AF XY: 0.000605 AC XY: 20AN XY: 33045
ClinVar
Submissions by phenotype
X-linked Alport syndrome Uncertain:1Benign:2
Benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Institute of Human Genetics, University of Leipzig Medical Center | Jan 01, 2019 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 28, 2018 | - - |
COL4A5-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 09, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at